Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
Cregge, R.J., Durham, S.L., Farr, R.A., Gallion, S.L., Hare, C.M., Hoffman, R.V., Janusz, M.J., Kim, H.O., Koehl, J.R., Mehdi, S., Metz, W.A., Peet, N.P., Pelton, J.T., Schreuder, H.A., Sunder, S., Tardif, C.(1998) J Med Chem 41: 2461-2480
- PubMed: 9651152 
- DOI: https://doi.org/10.1021/jm970812e
- Primary Citation of Related Structures:  
1B0E, 1B0F - PubMed Abstract: 
A series of P2-modified, orally active peptidic inhibitors of human neutrophil elastase (HNE) are reported. These pentafluoroethyl ketone-based inhibitors were designed using pentafluoroethyl ketone 1 as a model. Rational structural modifications were made at the P3, P2, and activating group (AG) portions of 1 based on structure-activity relationships (SAR) developed from in vitro (measured Ki) data and information provided by modeling studies that docked inhibitor 1 into the active site of HNE. The modeling-based design was corroborated with X-ray crystallographic analysis of the complex between 1 and porcine pancreatic elastase (PPE) and subsequently the complex between 1 and HNE.
Organizational Affiliation: 
Hoechst Marion Roussel Inc., 2110 East Galbraith Road, Cincinnati, Ohio 45215, USA.